Author: kwm107
-
Study Finds Biologic Drug ‘Highly Effective’ in Reducing Pediatric Eczema Symptoms
The first biologic drug to treat moderate-to-severe eczema in infants and children was highly effective in reducing symptoms, according to a recent study.
-
CRISPR Pioneer Jennifer Doudna Receives Inaugural Kimberly Prize
CRISPR pioneer and Nobel Laureate Jennifer Doudna, PhD is the recipient of the inaugural $250,000 Kimberly Prize in Biochemistry and Molecular Genetics.
-
Paller Receives 2022 Tripartite Award
Amy Paller, MD, the chair of and Walter J. Hamlin Professor of Dermatology, has been named the winner of the 2022 Tripartite Legacy Faculty Prize in Translational Science and Education.
-
Inside the Feinberg Curriculum: The Education-Centered Medical Home
Feinberg’s Education-Centered Medical Home program allows medical students to provide continuous, primary care to underserved and diverse patient populations, and to help them better understand chronic conditions in a variety of clinical settings.
-
Northwestern Awarded First-Ever National Grant to Study Wearables, Stroke Prevention in Patients With Atrial Fibrillation
Northwestern University has been awarded a seven-year grant to study a “pill-in-pocket” strategy to prevent stroke in patients with atrial fibrillation, the most common heart rhythm disorder in adults.
-
Coming Wave of Opioid Overdoses ‘Will be Worse Than Ever Been Before’
Geography played a role in opioid-involved overdose deaths in the past, but a coming wave may discriminate between rural and urban areas, according to a recent study.
-
Protein Transformation Drives Cancer Development
A change in function in a mitochondrial protein is associated with gene expression that may promote the development of cancer, according to a recent Northwestern Medicine Study.
-
Northwestern Launches New Center for Human Immunobiology
In the newly formed Center for Human Immunobiology, teams of interdisciplinary scientists and clinicians will work together to understand the immune system at the molecular level and translate new discoveries into cures for immune-regulated diseases.
-
Novel Telehealth Strategy Will Treat Three Cancer Risk Behaviors at Once
A new Northwestern Medicine trial will test whether a telehealth-based intervention that addresses three behavioral risk factors at once can modify cancer patients’ lifestyles to improve their outcomes.
-
Bigger is Better for Genetic Tests That Check for Cardiomyopathy, Arrhythmias
Bigger test panels are better for genetic testing in cardiomyopathy and heart arrhythmias, according to a recent Northwestern Medicine study.
